Expression data from ependymoma surgical samples
Ontology highlight
ABSTRACT: Ependymoma, the 3rd most common brain tumor in children, recurs in approximately 50% of patients. There is currently no robust marker that predicts for recurrence, which is a significant clinical problem We used global gene expression profiling of 19 patient surgical samples obtained at initial diagnosis and with known clinical outcomes to discover novel prognostic markers.
ORGANISM(S): Homo sapiens
PROVIDER: GSE16155 | GEO | 2009/10/01
SECONDARY ACCESSION(S): PRJNA117175
REPOSITORIES: GEO
ACCESS DATA